col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


32 Ergebisse       Seite 1

 [1] 
Springer (Biomed Central Ltd.): Molecular Medicine
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―16 Science tikkun: a bioscience pandemic framework in a Hebrew tradition of global repair Peter Hotez
2 [GO] 2025―Mai―06 A pilot study on the effect of SARS-CoV-2 spike protein on IL-1β-mediated inflammation in peripheral blood immune cells from AIED patients Shresh Pathak, Natalie Tan, Andrea Vambutas
3 [GO] 2025―Apr―23 An engineered miniACE2 protein secreted by mesenchymal stromal cells effectively neutralizes multiple SARS-CoV- 2 variants in vitro Sara Moreno-Jiménez, Gina Lopez-Cantillo, Jenny Andrea Arevalo-Romero, Ana María Perdomo-Arciniegas, Andrea Marisol Moreno-Gonzalez, Bellaneth Devia-Mejia, et al. (+3)
4 [GO] 2025―Mrz―15 miR-27a-5p, miR-21-5p, miR-1246 and miR-4508: a candidate microRNA signature in the protection and regulation of viral infection in mild COVID-19 Malena Gajate-Arenas, Candela Sirvent-Blanco, Omar García-Pérez, Angélica Domínguez-de-Barros, José E. Piñero, Jacob Lorenzo-Morales, Elizabeth Córdoba-Lanús
5 [GO] 2025―Jan―23 Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis Najeeha Talat Iqbal, Hana Khan, Aqsa Khalid, Syed Faisal Mahmood, Nosheen Nasir, Iffat Khanum, et al. (+2)
6 [GO] 2024―Aug―25 Alterations in plasma proteome during acute COVID-19 and recovery Maciej Suski, Agnieszka Olszanecka, Aneta Stachowicz, Anna Kiepura, Michał Terlecki, Józef Madej, et al. (+2)
7 [GO] 2024―Jun―19 Pathogenic mechanisms of cardiovascular damage in COVID-19 Hong-Hua Shao, Rui-Xing Yin
8 [GO] 2024―Jun―11 Multi-omics analysis uncovered systemic lupus erythematosus and COVID-19 crosstalk Zekai Nian, Yicheng Mao, Zexia Xu, Ming Deng, Yixi Xu, Hanlu Xu, et al. (+11)
9 [GO] 2024―Apr―17 The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis Maitray A. Patel, Douglas D. Fraser, Mark Daley, Gediminas Cepinskas, Noemi Veraldi, Serge Grazioli
10 [GO] 2023―Jan―26 Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS Richa Batra, Rie Uni, Oleh M. Akchurin, Sergio Alvarez-Mulett, Luis G. Gómez-Escobar, Edwin Patino, et al. (+13)
11 [GO] 2022―Dez―12 Host genetic susceptibility underlying SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Brazilian Children Cíntia Barros Santos-Rebouças, Rafael Mina Piergiorge, Cristina dos Santos Ferreira, Raquel de Seixas Zeitel, Alexandra Lehmkuhl Gerber, Marta Cristine Felix Rodrigues, et al. (+9)
12 [GO] 2022―Nov―08 Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial Sergio Fragoso-Saavedra, Isaac Núñez, Belem M. Audelo-Cruz, Sarahi Arias-Martínez, Daniel Manzur-Sandoval, Alejandro Quintero-Villegas, et al. (+20)
13 [GO] 2022―Aug―19 Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients Etianne Martini Sasso, Katsuhiko Muraki, Natalie Eaton-Fitch, Peter Smith, Olivia Ly Lesslar, Gary Deed, Sonya Marshall-Gradisnik
14 [GO] 2022―Aug―03 Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis Samaneh Maleknia, Mohammad Javad Tavassolifar, Faezeh Mottaghitalab, Mohammad Reza Zali, Anna Meyfour
15 [GO] 2022―Apr―09 The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo Lucía Beltrán-Camacho, Sara Eslava-Alcón, Marta Rojas-Torres, Daniel Sánchez-Morillo, Mª Pilar Martinez-Nicolás, Victoria Martín-Bermejo, et al. (+5)
16 [GO] 2021―Dez―27 Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection Svetlana P. Chapoval, Achsah D. Keegan
17 [GO] 2021―Dez―20 Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection Catherine Chen, Aisah Amelia, George W. Ashdown, Ivo Mueller, Anna K. Coussens, Emily M. Eriksson
18 [GO] 2021―Dez―20 Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach Jamilet Miranda, Ricardo Bringas, Jorge Fernandez-de-Cossio, Yasser Perera-Negrin
19 [GO] 2021―Dez―03 Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19 Dong Zhang, Liubing Li, Yu Chen, Jie Ma, Yanli Yang, Surita Aodeng, et al. (+6)
20 [GO] 2021―Okt―18 CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study Nicola I. Lorè, Rebecca De Lorenzo, Paola M. V. Rancoita, Federica Cugnata, Alessandra Agresti, Francesco Benedetti, et al. (+36)
21 [GO] 2021―Sep―26 Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues Martin Begemann, Oliver Gross, Dominik Wincewicz, Rüdiger Hardeland, Vinicius Daguano Gastaldi, Eduard Vieta, et al. (+4)
22 [GO] 2021―Sep―16 Extreme immunotherapy: emergency immunology to defeat pandemics Douglas F. Nixon, Daniela Marín-Hernández, Nathaniel Hupert
23 [GO] 2021―Sep―09 Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry Rodrigo R. R. Duarte, Dennis C. Copertino, Luis P. Iñiguez, Jez L. Marston, Yaron Bram, Yuling Han, et al. (+4)
24 [GO] 2021―Mai―31 Heterologous vaccine interventions: boosting immunity against future pandemics Daniela Marín-Hernández, Douglas F. Nixon, Nathaniel Hupert
25 [GO] 2021―Mai―22 Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines Jianhua Li, Ping Wang, Kevin J. Tracey, Haichao Wang
26 [GO] 2021―Mrz―26 Essential properties and pitfalls of colorimetric Reverse Transcription Loop-mediated Isothermal Amplification as a point-of-care test for SARS-CoV-2 diagnosis Bruna de Oliveira Coelho, Heloisa Bruna Soligo Sanchuki, Dalila Luciola Zanette, Jeanine Marie Nardin, Hugo Manuel Paz Morales, Bruna Fornazari, et al. (+2)
27 [GO] 2020―Nov―10 SARS-CoV-2 and interferon blockade Betty Diamond, Bruce T. Volpe, Sonya VanPatten, Yousef Al Abed
28 [GO] 2020―Okt―29 IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19 Yu Chen, Jinglan Wang, Chenxi Liu, Longxiang Su, Dong Zhang, Junping Fan, et al. (+6)
29 [GO] 2020―Sep―29 Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series Andrew G. Weber, Alice S. Chau, Mikala Egeblad, Betsy J. Barnes, Tobias Janowitz
30 [GO] 2020―Aug―17 Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19? Pawel Namsolleck, Gert N. Moll
31 [GO] 2020―Jun―16 Erythropoietin as candidate for supportive treatment of severe COVID-19 Hannelore Ehrenreich, Karin Weissenborn, Martin Begemann, Markus Busch, Eduard Vieta, Kamilla W. Miskowiak
32 [GO] 2020―Mai―07 Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Ulf Andersson, William Ottestad, Kevin J. Tracey
 [1] 

32 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec